GENSCRIPT BIOTECH CORPORATIONGENSCRIPT BIOTECH CORPORATIONGENSCRIPT BIOTECH CORPORATION

GENSCRIPT BIOTECH CORPORATION

No trades
See on Supercharts

1548 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

1548 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company